4d7f
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Human FXIa in complex with small molecule inhibitors.== | ==Human FXIa in complex with small molecule inhibitors.== | ||
- | <StructureSection load='4d7f' size='340' side='right' caption='[[4d7f]], [[Resolution|resolution]] 1.62Å' scene=''> | + | <StructureSection load='4d7f' size='340' side='right'caption='[[4d7f]], [[Resolution|resolution]] 1.62Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4d7f]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4D7F OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4D7F FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4d7f]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4D7F OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4D7F FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=IXA:N-[(2S)-1-({4-[(DIAMINOMETHYLIDENE)AMINO]BUTYL}AMINO)-1-OXO-3-PHENYLPROPAN-2-YL]-4-HYDROXY-2-OXO-1,2-DIHYDROQUINOLINE-6-CARBOXAMIDE'>IXA</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=IXA:N-[(2S)-1-({4-[(DIAMINOMETHYLIDENE)AMINO]BUTYL}AMINO)-1-OXO-3-PHENYLPROPAN-2-YL]-4-HYDROXY-2-OXO-1,2-DIHYDROQUINOLINE-6-CARBOXAMIDE'>IXA</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4d76|4d76]], [[4d7g|4d7g]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4d76|4d76]], [[4d7g|4d7g]]</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Coagulation_factor_XIa Coagulation factor XIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.27 3.4.21.27] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Coagulation_factor_XIa Coagulation factor XIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.27 3.4.21.27] </span></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4d7f FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4d7f OCA], [http://pdbe.org/4d7f PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4d7f RCSB], [http://www.ebi.ac.uk/pdbsum/4d7f PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4d7f FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4d7f OCA], [http://pdbe.org/4d7f PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4d7f RCSB], [http://www.ebi.ac.uk/pdbsum/4d7f PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4d7f ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
Line 12: | Line 13: | ||
== Function == | == Function == | ||
[[http://www.uniprot.org/uniprot/FA11_HUMAN FA11_HUMAN]] Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX. | [[http://www.uniprot.org/uniprot/FA11_HUMAN FA11_HUMAN]] Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX. | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Factor XIa|Factor XIa]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
Line 17: | Line 21: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Coagulation factor XIa]] | [[Category: Coagulation factor XIa]] | ||
+ | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Akerud, T]] | [[Category: Akerud, T]] | ||
[[Category: Borjesson, U]] | [[Category: Borjesson, U]] |
Revision as of 07:55, 27 March 2019
Human FXIa in complex with small molecule inhibitors.
|
Categories: Coagulation factor XIa | Human | Large Structures | Akerud, T | Borjesson, U | Jacso, T | Norberg, M | Olsson, T | Oster, L | Redzick, A | Sandmark, J | Ullah, V | Hydrolase | Serine protease